Welcome to the international HTA database

Showing [24133 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	Canary Health Service	[Therapeutic management of retinitis pigmentosa]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Therapeutic management of colorectal cancer patients with liver metastases based on the presence of disseminated tumor cells in bone marrow]
2007	Canary Health Service	[Therapeutic interventions in the treatment of mental illness in children]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients with stroke or brain trauma]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Therapeutic hypothermia in patients who underwent cardiac arrest resuscitation]
2009	The Swedish Council on Health Technology Assessment (SBU)	[Therapeutic hypothermia following perinatal asphyxia]
2009	Committee for New Health Technology Assessment (CNHTA)	[The vest airway clearance system]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The value of F-18-fluorodeoxyglucose positron emission tomography for detection of metastatic infectious foci complicating Gram-positive bacteremia (MI-PET)]
2024	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[The utility of neuropsychological tests for the detection and diagnosis of frontotemporal dementia (FTD)]
2022	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[The use of social media and electronic communication in the delivery of youth protection services to young people in difficulty and their families]
2001	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[The use of neuroimaging in dementia evaluation. A medical technology report]
2005	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[The use of liquid based cytology (LBC) and conventional pap smear (CPS) for cervical screening in Denmark]
2001	Basque Office for Health Technology Assessment (OSTEBA)	[The use of inhalation chambers in the treatment of infantile asthma]
2020	HTA South	[The use of hydrogel spacer in radiotherapy of prostate cancer]
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	[The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2007	The Netherlands Organisation for Health Research and Development (ZonMw)	[The use of autologous cord blood for anemia of prematurity]
2008	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The treatment of parkinson's disease with dopamine agonists]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The treatment of depression in primary care: the efficiency of computerised cognitive behaviour therapy]
2010	National Evidence-based Healthcare Collaborating Agency (NECA)	[The survey and cross-sectional analysis of palliative radiotherapy for bone metastases to facilitate its proper use in cancer patients]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[The status and dissemination plan of clinical practice guidelines in Korea]
2009	Andalusian Health Technology Assessment Area (AETSA)	[The state of research into inequalities in the incidence, death, prevention and healthcare in cancer in Spain. A bibliometric study and literature review.]
2004	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[The screening of congenital adrenal hyperplasia. Applicability in Galicia]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[The scientific knowledge base for treatment of patients with cleft lip, alveolus and palate]
2005	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[The role of vascular endoprostheses in the treatment of intracranial aneurysms]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The role of homocysteine as a predictor for coronary heart disease]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The role of homocysteine as a predictor for coronary heart disease]
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[The relevance of the neonatal urine screening for inborn errors of metabolism performed in Quebec]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The relationship between the cost-effectiveness of blood safety measures and the distribution of patients receiving blood]
2007	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[The practice of percutaneous coronary interventions in hospitals without on-site cardiac surgery: review of guidelines and analysis of Quebec data, 1999-2004]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The potential influence of socio-demographical factors on access to and results of rehabilitation]
2012	Haute Autorite de sante (HAS)	[The place of and conditions for carrying out polysomnography and respiratory polygraphy in sleep disorders]
2004	Unit of Health Economics and Technology Assessment in Health Care (HunHTA)	[The most often used androgen receptor blockers (flutamide, bicalutamide, nilutamide) in prostate cancer; systematic review of the clinical and economic literature]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[The mortality rate and medical costs identified by a national health examination analysis]
2024	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[The mental health day hospital: drawing on the literature to define the service offer and enhance practice]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The Measles-Mumps-Rubella vaccination from a health political and economical point of view]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The measels-mumps-rubella vaccination from a health political and economical point of view]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The Mandometer method versus conventional treatment; predictors of early treatment efficacy and relapse in anorexia nervosa patients treated with the Mandometer method or conventional treatment]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The Manchester triage system in paediatric emergency care]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The long run - short run efficiency paradox in health care]
2018	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[The LifeVest wearable defibrillator in the prevention of risk for sudden cardiac arrest]
2007	Norwegian Knowledge Centre for the Health Services (NOKC)	[The influence of hospital or physician volume on quality of health care]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The implementation of a guideline on the management of the lumbosacral radicular syndrome among general practitioners, physiotherapists, radiologists, neurologists, neurologic surgeons and orthopedic surgeons: a shared care project in two hospitals]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The impact of microsurgery, stereotactic radiosurgery and radiotherapy in the treatment of meningiomas depending on different localizations]
2002	Basque Office for Health Technology Assessment (OSTEBA)	[The identification of emerging health technologies. Document for the SorTek network]
2009	Health Council of the Netherlands Gezondheidsraad (GR)	[The hospital as a healing environment]
2003	Basque Office for Health Technology Assessment (OSTEBA)	[The health, economic and social impact of low back pain in the Autonomous Community of the Basque Country]
2000	Finnish Office for Health Care Technology Assessment (Finohta)	[The feasibility of randomised controlled trials]
2010	National Evidence-based Healthcare Collaborating Agency (NECA)	[The evidence of korean guidelines for the use of lipid lowering agents: drug utilization review and outcomes research]
2001	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[The establishment of a Danish early warning system for emerging technologies. Report from a pilot project]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[The efficacy of rehabilitative interventions and pharmacological treatments for children aged 2 to 12 years with autism spectrum disorder (ASD)]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The efficacy of 'Radioguided Occult Lesion Localization' (ROLL) versus 'Wire-guided Localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized controlled trial]
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[The effects of tangible and intangible incentives on health behaviour]
2010	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effects of school health services for children and young people's health and growing up conditions]
2005	Finnish Office for Health Care Technology Assessment (Finohta)	[The effects of preventive home visits on the functional capacity of older people. A technology assessment based on systematic literature reviews.]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence]
2011	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effects of group education on patients and their next of kin]
2000	Finnish Office for Health Care Technology Assessment (Finohta)	[The effects of extending the use of mammography screening: a report on the cost-effectiveness of breast cancer screening in 60 to 69 year-old women]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The effects and costs of cranberry use to prevent clinical urinary tract infections in nursing home residents]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of primary interventions to prevent the use of tobacco, alcohol and other drugs among children and adolescents]
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of occupational therapy for persons with moderate and severe dementia]
2013	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of occupational therapy for persons with moderate and severe dementia]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personnel]
2011	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personal]
2012	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effectiveness of health promotion and preventive interventions on nutrition, physical activity, obesity, and sexual health in children and adolescents]
2005	Finnish Office for Health Care Technology Assessment (Finohta)	[The effectiveness of family interventions. A systematic literature review on controlled trials]
2002	Basque Office for Health Technology Assessment (OSTEBA)	[The effectiveness and safety of different forms of treating prostate cancer]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effect of rehabilitation on social and community participation]
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effect of infection control interventions in day-care facilities and schools]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[The economic analysis of robotic surgery for prostate cancer]
2010	National Evidence-based Healthcare Collaborating Agency (NECA)	[The disease burden of seasonal influenza and the effectiveness of seasonal influenza vaccination in Korea]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[The diagnostic accuracy of infrared tympanic, oral, axillary and temporal thermometry, compared with rectal readings when identifying fever in adult hospitalized patients]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The DExamethasone for Cardiac Surgery (DECS) trial: a large but simple trial to quantify the cost-effectiveness of dexamethasone in patients undergoing cardiac surgery]
2011	Basque Office for Health Technology Assessment (OSTEBA)	[The development of the set of basic data on specialised ambulatory care (SBD-SAC) of Osakidetza. Pilot scheme in three hospitals]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[The development and piloting of a multidisciplinary collaborative program for the comprehensive care of patients diagnosed with heart failure (HF) – PROMIC]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of ST analysis of the fetal electrocardiogram as compared to fetal blood sampling for intrapartum fetal monitoring: a randomised controlled trial]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of NT-pro-brain natriuretic peptide (NT-proBNP) guided therapy of chronic heart failure]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[The cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus center]
2008	Center for Medical Technology Assessment (CMT)	[The cost of ill-health - a survey of consumption of health care services for different disease groups in the county of Ostergotland, Sweden]
2009	Basque Office for Health Technology Assessment (OSTEBA)	[The coordination between primary and specialized healthcare from the point of view of the professionals]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[The coblation technique in tonsillectomy]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[The clinical usefulness and cost-effectiveness of CT coronary angiography for the diagnosis of ischemic heart disease in patients with chest pain]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[The clinical effectiveness and economic analysis of bariatric surgery for severe obesity]
2012	Institute for Clinical Effectiveness and Health Policy (IECS)	[The Benozzi® method (pilocarpine eye drops) for the treatment of presbyopia]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[The application of GRADE in the development of a CPG on childhood asthma]
1998	Finnish Office for Health Care Technology Assessment (Finohta)	[The annual costs of medical technology]
2005	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[The 13C-urea breath test for detection of helicobacter pylori: potential applications in Quebec ]
2008	Committee for New Health Technology Assessment (CNHTA)	[TGFBR2 gene mutation analysis]
2008	Committee for New Health Technology Assessment (CNHTA)	[TGFBR1 gene mutation analysis]
2008	Committee for New Health Technology Assessment (CNHTA)	[TGFB1 gene, mutation[sequencing]]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezepelumab (severe asthma) - Benefit assessment according to § 35a SGB V]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezacaftor/ivacaftor (cystic fibrosis) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 6 to < 12 years, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code Book V]
2021	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 6 to < 12 years, F508del mutation, heterozygous) - Benefit assessment according to §35a Social Code Book V]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, homozygous) - Benefit assessment according to §35a Social Code Book V]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tezacaftor/ivacaftor (combination with ivacaftor; cystic fibrosis, 12 years and older, F508del mutation, heterozygous) - Benefit assessment according to §35a Social Code Book V]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Testing of a method for assessing the internal validity of guideline recommendations, using the example of evidence-based guidelines on preoperative diagnostics]